Tumour necrosis factor inhibitors in ankylosing spondylitis.

Abstract

Ankylosing spondylitis (AS) is the most common form of spondyloarthropathy. Non-steroidal anti-inflammatory medications and exercise are used to manage the chronic inflammatory spinal pain and stiffness. Up to 20% of patients have a peripheral inflammatory arthritis, which is treated with standard disease-modifying anti-rheumatic drugs especially… (More)
DOI: 10.1111/j.1445-5994.2008.01639.x

Topics

Cite this paper

@article{Reed2008TumourNF, title={Tumour necrosis factor inhibitors in ankylosing spondylitis.}, author={Michael Reed and Adrian Taylor}, journal={Internal medicine journal}, year={2008}, volume={38 10}, pages={781-9} }